Ogilvie syndrome medical therapy: Difference between revisions
(Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Ogilvie syndrome}} {{CMG}} ==Overview== =...") |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
It usually resolves with conservative therapy stopping oral ingestions, i.e. [[nil per os]] and a [[Feeding tube|nasogastric tube]], | It usually resolves with conservative therapy stopping oral ingestions, i.e. [[nil per os]] and a [[Feeding tube|nasogastric tube]], but may require [[colonoscopy|colonoscopic]] decompression which is successful in 70% of the cases. A study published in the [[New England Journal of Medicine]] showed that [[neostigmine]] is a potent pharmacological way of decompressing the colon. According to the American Society for Gastrointestinal Endoscopy (ASGE), it should be considered prior to colonoscopic decompression. The use of neostigmine is not without risk since it can induce bradyarrhythmia and bronchospasms. Therefore atropine should be within immediate reach when this therapy is used. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Revision as of 20:08, 4 September 2012
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
| Ogilvie syndrome Microchapters
|
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ogilvie syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Ogilvie syndrome medical therapy |
|
Risk calculators and risk factors for Ogilvie syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
It usually resolves with conservative therapy stopping oral ingestions, i.e. nil per os and a nasogastric tube, but may require colonoscopic decompression which is successful in 70% of the cases. A study published in the New England Journal of Medicine showed that neostigmine is a potent pharmacological way of decompressing the colon. According to the American Society for Gastrointestinal Endoscopy (ASGE), it should be considered prior to colonoscopic decompression. The use of neostigmine is not without risk since it can induce bradyarrhythmia and bronchospasms. Therefore atropine should be within immediate reach when this therapy is used.